DNA Nanorobots & AI could slash drug development times, Nanovery CEO says
AGC Biologics powers commercial launch of its life-changing gene therapy for rare childhood immune disorder
China nod to first homegrown BNCT cancer drug for human trials
AbbVie’s Epcoritamab shows progression-free survival gain in relapsed/refractory DLBCL trial
China nod to two Sanofi drugs for rare and complex conditions
IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
Symeres rehires Jurgen Berendsen as CFO amid strategic growth push
Avalon clinches majority investment to expand future of diagnostic intelligence
Alto Neuroscience bags new US patent for depression drug ALTO-207
Kindeva appoints David Stevens as new CEO
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
